Cipla Medpro South Africa LtdCMP:JNB

Add to portfolio
Set alert
Interactive chart
Historical prices
Data definitions
957.00
2.00 / 0.21%
723.50k
27.60%
0.1899
Close in ZAXToday's changeShares traded1 year changeBeta
As of May 24 2013 16:01 BST.Data delayed by at least 30 minutes.

Interactive chart

Summary

On Friday, Cipla Medpro South Africa Ltd (CMP:JNB) closed at 957.00, 2.35% below its 52-week high of 980.00, set on Feb 28, 2013.

52-week range
Today
630.00
Sep 26 2012
980.00
Feb 28 2013
Markit short selling activity
Low
Medium
High
What is this
Open955.00
Day high959.00
Day low955.00
Bid957.00
Offer959.00
Previous close959.00
Average volume2.98m
Shares outstanding446.49m
Free float326.06m
P/E (TTM)26.41
Market cap4.28bn ZAR
EPS (TTM)0.3631 ZAR
Annual div (TTM)13.60 ZAX
Annual div yield (TTM)1.42%
Div ex-dateOct 01 2012
Div pay-dateOct 08 2012

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Cipla Medpro South Africa Ltd-0.21%+1.70%+13.25%+27.60%+235.79%
ALL SHARE-1.00%+5.71%+8.27%+24.06%+25.99%
ZA/HEALTH CARE-1.57%+5.14%+21.01%+34.85%--
ZA/PHARMACEUTICALS-2.71%+8.96%+25.26%+44.15%--
As of May 24 2013 16:01 BST.Data delayed by at least 30 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.